PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+43.99%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$339M
AUM Growth
–
Cap. Flow
+$339M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
38.61%
Holding
69
New
68
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Merck
MRK
|
$20M |
| 2 |
Neurocrine Biosciences
NBIX
|
$16.7M |
| 3 |
Zimmer Biomet
ZBH
|
$14.2M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$13.7M |
| 5 |
Kodiak Sciences
KOD
|
$12.6M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 93.8% |
| 2 | Industrials | 0.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MTEM
26
DELISTED
Molecular Templates, Inc.
MTEM
| $4.78M | 1.38% |
+341,695
| New | +$4.78M |
|
|
ICAD
27
DELISTED
iCAD Inc
ICAD
| $4.67M | 1.35% |
+600,686
| New | +$4.67M |
|
|
AXNX
28
DELISTED
Axonics, Inc. Common Stock
AXNX
| $4.61M | 1.33% |
+166,231
| New | +$4.61M |
|
29
Alnylam Pharmaceuticals
ALNY
$58.5B
| $4.03M | 1.16% |
+35,000
| New | +$4.03M |
|
|
MSON
30
DELISTED
Misonix Inc
MSON
| $3.96M | 1.14% |
+212,500
| New | +$3.96M |
|
31
BioCryst Pharmaceuticals
BCRX
$1.74B
| $3.94M | 1.14% |
+1,141,212
| New | +$3.94M |
|
32
Regenxbio
RGNX
$451M
| $3.48M | 1.01% |
+85,000
| New | +$3.48M |
|
33
KORU Medical Systems
KRMD
$195M
| $3.45M | 1% |
+528,572
| New | +$3.45M |
|
|
RETA
34
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $3.27M | 0.94% |
+16,000
| New | +$3.27M |
|
35
Ascendis Pharma
ASND
$11.8B
| $3.2M | 0.92% |
+23,004
| New | +$3.2M |
|
36
Alphatec Holdings
ATEC
$2.35B
| $3.19M | 0.92% |
+450,000
| New | +$3.19M |
|
|
XENT
37
DELISTED
Intersect ENT, Inc
XENT
| $3.13M | 0.9% |
+125,500
| New | +$3.13M |
|
|
FOMX
38
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $3.1M | 0.9% |
+932,141
| New | +$3.1M |
|
39
Halozyme
HALO
$8.56B
| $2.93M | 0.84% |
+165,000
| New | +$2.93M |
|
|
AMRN
40
Amarin Corp
AMRN
$311M
| $2.91M | 0.84% |
+135,676
| New | +$2.91M |
|
41
OrthoPediatrics
KIDS
$536M
| $2.82M | 0.81% |
+60,000
| New | +$2.82M |
|
42
Stereotaxis
STXS
$261M
| $2.81M | 0.81% |
+531,718
| New | +$2.81M |
|
43
BioLife Solutions
BLFS
$1.2B
| $2.69M | 0.78% |
+166,000
| New | +$2.69M |
|
|
RCM
44
DELISTED
R1 RCM Inc. Common Stock
RCM
| $2.67M | 0.77% |
+205,720
| New | +$2.67M |
|
45
Guardant Health
GH
$8.41B
| $2.36M | 0.68% |
+30,250
| New | +$2.36M |
|
|
PVLA
46
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $2.25M | 0.65% |
+621,511
| New | +$2.25M |
|
47
iRadimed
IRMD
$921M
| $2.19M | 0.63% |
+93,500
| New | +$2.19M |
|
48
Aurinia Pharmaceuticals
AUPH
$1.58B
| $2.03M | 0.58% |
+100,000
| New | +$2.03M |
|
|
GNMK
49
DELISTED
GenMark Diagnostics, Inc
GNMK
| $2.02M | 0.58% |
+420,000
| New | +$2.02M |
|
50
Nephros
NEPH
$39.5M
| $1.99M | 0.57% |
+199,724
| New | +$1.99M |
|